Track market-moving stories before they get noisy

Alcoa Corp. NYSE: AA stock has been cut nearly in half since its spring peak. Shares traded near $77 in May and were trading near $40 prior to the company's Q3 2026 earnings report, which the company delivered after the market closed on Oct. 15.

Alcoa Today

$41.38 -0.08 (-0.18%)

As of 03:01 PM Eastern

This is a fair market value price provided by Massive. Learn more.

$35.12▼

$84.380.97%

7.15

$62.17

That kind of drawdown usually signals a broken business or a collapsing commodity. Alcoa has neither. Aluminum prices have cooled from their spring highs, but they have not followed the stock down. Alcoa’s average realized aluminum price fell about 5% from the second quarter to the third. AA shares fell roughly ten times that.

Get Alcoa alerts:

That gap set up the real question that Alcoa needed to answer with its report. Had the market confused a temporary operational problem with a peak in the aluminum cycle?

The operational problem is real. Instability at the Pinjarra refinery in Australia pushed the Alumina segment to a $96 million EBITDA loss in Q2. Add July’s earnings miss, and the “peak earnings” story writes itself.

The Q3 report provided a bullish rebuttal. Pinjarra is stable again. Aluminum margins remain near record levels. And Alcoa beat earnings expectations while producing its strongest free cash flow of the year.

Pinjarra Refinery Recovery Drives an Alumina ReboundAlumina production jumped 11% sequentially to 2.5 million metric tons. Management credited improved stability at Pinjarra. Segment EBITDA improved to a loss of just $1 million. That's a $95 million swing in one quarter.

Costs fell. Adjusted operating cost per ton of alumina dropped to $354 from $368. This came while realized alumina prices rose to $353 per ton from $334.

This is evidence of a temporary problem that is in the process of resolving itself. Management expects Alumina performance to hold steady in Q4 rather than slip back.

Aluminum Margins Remain Strong Despite Lower PricesAluminum segment EBITDA fell to $862 million from Q2’s record $1.07 billion. Bears will point to that decline. But context matters.

Two factors drove most of the drop. Realized aluminum prices slipped to $4,527 per ton from $4,752. Shipments fell 5% after Q2 volumes were inflated by inventory moves from Q1. Additionally, higher carbon costs added pressure.

Viewed from that lens, this doesn't look like a cycle rolling over. Q3 aluminum EBITDA was still nearly triple the $307 million from a year ago. The segment kept a margin above 28% of third-party sales.

Production kept climbing, too. Aluminum output rose for the sixth straight quarter to 649,000 metric tons. The Alumar smelter restart in Brazil is complete. Five smelters and one refinery set year-to-date production records.

Alcoa Q3 2026 Earnings Beat EstimatesAdjusted earnings per share (EPS) came in at $1.82, ahead of the $1.51 consensus. GAAP EPS rose to $1.81 from $1.53 in Q2. A year ago, adjusted EPS was a 2-cent loss.

Cash flow tells the same story. Operating cash flow was $643 million. Free cash flow reached $472 million, up from $422 million in Q2. A year ago, free cash flow was negative.

The balance sheet is ready for the AliGroup acquisition. Alcoa holds $4.4 billion in cash after a $2.6 billion bond sale. Net debt is just $414 million. South32 shareholders approved the deal on report day. Closing is expected in the first half of 2027.

Why Alcoa Stock Remains Near Its Lows Despite Strong ResultsSo why is the stock still near its lows? Partly because the market prices aluminum stocks on the next move in metal, not the last quarter.

Q4 guidance does carry modest headwinds. Management sees about $30 million in higher raw material and maintenance costs in Aluminum. Higher alumina input costs should add another $30 million. Interest expense is also rising after the bond deal.

Those are real, but small against an $862 million quarterly segment result. Management also expects higher production and shipments in both segments in Q4.

The chart reflects exhausted selling more than new information. Shares sit below a declining 50-day moving average near $47. AA bounced nearly 5% the morning after earnings. This pushed the 14-day RSI out of oversold territory, where it was before the report.

Key Risks and Catalysts for AA SharesThe bull case doesn’t require aluminum to rally. It requires aluminum to stay elevated while Alcoa’s operations keep improving. Q3 delivered both.

The risk is a further slide in metal prices. LME moves flow directly through the Aluminum segment. A sharp drop would validate the market’s peak-cycle read.

But this report points the other way. The operational issue behind the sell-off is resolved. Margins remain near historic highs. And the stock is priced as if neither were true.

That disconnect is the opportunity. The market sold Alcoa on a refinery problem and cycle fears. The quarter fixed the refinery. The cycle hasn’t turned.

Should You Invest $1,000 in Alcoa Right Now?Before you consider Alcoa, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alcoa wasn't on the list.

While Alcoa currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

First Bank & Trust purchased a new stake in Marvell Technology, Inc. (NASDAQ:MRVL – Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 10,188 shares of the semiconductor company’s stock, valued at approximately $2,692,000.

Other institutional investors have also recently added to or reduced their stakes in the company. FIDELIS iM LLC purchased a new stake in Marvell Technology during the 3rd quarter valued at approximately $275,000. IFP Advisors Inc acquired a new stake in Marvell Technology during the 3rd quarter worth approximately $16,435,000. Founders Grove Wealth Partners LLC purchased a new position in shares of Marvell Technology in the 3rd quarter valued at approximately $226,000. CRA Financial Services LLC purchased a new position in shares of Marvell Technology in the 3rd quarter valued at approximately $7,775,000. Finally, Strata Wealth Advisors LLC purchased a new position in shares of Marvell Technology in the 3rd quarter valued at approximately $312,000. Institutional investors and hedge funds own 83.51% of the company’s stock.

Marvell Technology Price Performance
Shares of NASDAQ:MRVL opened at $227.83 on Monday. The company has a quick ratio of 2.62, a current ratio of 3.17 and a debt-to-equity ratio of 0.27. The company has a market cap of $199.78 billion, a P/E ratio of 75.19, a PEG ratio of 6.79 and a beta of 2.26. Marvell Technology, Inc. has a 52 week low of $70.68 and a 52 week high of $329.88. The company has a 50-day moving average price of $241.14 and a 200 day moving average price of $217.01.

Marvell Technology (NASDAQ:MRVL – Get Free Report) last announced its quarterly earnings data on Thursday, August 27th. The semiconductor company reported $0.94 earnings per share for the quarter, beating analysts’ consensus estimates of $0.93 by $0.01. Marvell Technology had a return on equity of 13.57% and a net margin of 27.93%. The company had revenue of $2.74 billion for the quarter, compared to analyst estimates of $2.72 billion. During the same quarter in the previous year, the company earned $0.67 EPS. The firm’s revenue for the quarter was up 36.5% compared to the same quarter last year. Marvell Technology has set its Q3 2027 guidance at 1.050-1.150 EPS. Research analysts predict that Marvell Technology, Inc. will post 3.05 earnings per share for the current year.
Marvell Technology Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 29th. Investors of record on Friday, October 9th will be paid a $0.06 dividend. The ex-dividend date is Friday, October 9th. This represents a $0.24 dividend on an annualized basis and a dividend yield of 0.1%. Marvell Technology’s payout ratio is 7.92%.

Insiders Place Their Bets
In related news, insider Sandeep Bharathi sold 3,685 shares of the company’s stock in a transaction on Friday, October 16th. The stock was sold at an average price of $234.97, for a total transaction of $865,864.45. Following the transaction, the insider owned 58,748 shares of the company’s stock, valued at $13,804,017.56. This represents a 5.90% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Chris Koopmans sold 10,000 shares of the stock in a transaction on Monday, August 3rd. The stock was sold at an average price of $180.50, for a total value of $1,805,000.00. Following the completion of the transaction, the chief operating officer owned 227,941 shares of the company’s stock, valued at $41,143,350.50. The trade was a 4.20% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 57,285 shares of company stock worth $12,837,063. Insiders own 0.12% of the company’s stock.

Key Headlines Impacting Marvell Technology
Here are the key news stories impacting Marvell Technology this week:

Positive Sentiment: Marvell’s recent Investor Day highlighted strong expected demand for custom AI chips, data-center infrastructure and networking silicon. The company raised its long-term sales outlook, supporting the view that it could deliver substantial revenue and earnings growth. Long-term Marvell growth outlook
Positive Sentiment: Erste Group Bank reportedly increased its earnings-per-share forecast for Marvell, while other analysts remain optimistic about the company’s growth potential in AI and data-center markets. Marvell EPS forecast increase
Neutral Sentiment: CEO Matthew Murphy sold 7,500 shares, and insider Sandeep Bharathi sold 3,685 shares. Both transactions were conducted under pre-arranged Rule 10b5-1 plans to cover tax withholding tied to vested equity awards, reducing their significance as signals about the company’s outlook. Marvell CEO SEC filing Marvell insider SEC filing
Negative Sentiment: Broadcom CEO Hock Tan’s warning about the amount of capital required to fund AI infrastructure is weighing on custom AI-chip companies, including Marvell. Investors fear that hyperscalers may become more selective with spending or demand better returns, particularly after Marvell’s substantial rally. Broadcom AI funding warning
Negative Sentiment: Hotter U.S. inflation data and rising interest-rate expectations have triggered a broader technology and semiconductor sell-off. High-growth stocks such as Marvell are particularly vulnerable because their valuation depends heavily on future AI-driven earnings. Marvell market pressure

Wall Street Analyst Weigh In
A number of research analysts have recently issued reports on MRVL shares. Oppenheimer reissued an “outperform” rating and issued a $425.00 target price on shares of Marvell Technology in a report on Wednesday, October 7th. DA Davidson set a $225.00 price target on Marvell Technology in a report on Tuesday, August 18th. Erste Group Bank downgraded Marvell Technology from a “buy” rating to a “hold” rating in a report on Wednesday, July 15th. Barclays reiterated an “overweight” rating on shares of Marvell Technology in a research report on Thursday, August 20th. Finally, Morgan Stanley boosted their price objective on shares of Marvell Technology from $268.00 to $300.00 and gave the company an “equal weight” rating in a research note on Wednesday, October 7th. Two research analysts have rated the stock with a Strong Buy rating, thirty have given a Buy rating and seven have assigned a Hold rating to the stock. According to MarketBeat, Marvell Technology currently has an average rating of “Moderate Buy” and an average target price of $327.36.

View Our Latest Stock Analysis on Marvell Technology

Marvell Technology Profile
(Free Report)

Marvell Technology, Inc (NASDAQ: MRVL) is a semiconductor company that develops infrastructure solutions for data centers, telecommunications networks, enterprise systems, automotive applications and other connected markets. Its products are designed to support the movement, processing, storage and security of data across complex computing and communications environments.

The company’s portfolio includes data-processing and networking processors, custom application-specific integrated circuits, Ethernet switches and controllers, storage controllers, connectivity products, and electro-optics solutions.

Featured Stories

Five stocks we like better than Marvell Technology
These 3 Green Stocks Have a Growth Story That Goes Far Beyond Washington
Meta Claims Frontier-Class AI Status With New Muse Wonder Models
Berkshire Just Backed This Little-Known Stock—Should You Chase It?
Broadcom’s CEO Sees Years of AI Demand But Warns of a Bigger Threat to the Boom

Receive News & Ratings for Marvell Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marvell Technology and related companies with MarketBeat.com's FREE daily email newsletter.

Arista Networks (ANET +3.22%) is scheduled to report third-quarter earnings on Nov. 3, but I think the most important numbers in the report won't have anything to do with the third quarter.

Instead, I'll be watching what management says about the final three months of 2026.

According to Yahoo Finance, Wall Street expects the artificial intelligence (AI) networking company to generate $3.6 billion in fourth-quarter revenue and earnings of $1.15 per share. Those are some pretty ambitious targets, but I think Arista has a good chance to exceed them.

And if management delivers guidance that beats those expectations, I think Arista stock could soar after Nov. 3.

Image source: Getty Images.

Why fourth-quarter guidance matters
Arista has become an important supplier of the high-speed networking equipment that connects processors and servers inside massive artificial intelligence data centers.

Companies such as Nvidia are developing increasingly powerful graphics processing units (GPUs), but those chips can't reach their full potential unless enormous amounts of information can move between them quickly.

Arista makes Ethernet switches that help eliminate networking bottlenecks, allowing thousands of processors to work together on demanding AI applications.

The company reported second-quarter revenue of $3.03 billion, a 37.7% increase from a year ago. Diluted earnings per share reached $0.95, compared with $0.70 in the year-earlier period. Management also projected third-quarter revenue of approximately $3.3 billion.

That's in line with what Wall Street projects. According to Yahoo Finance, the consensus Q3 estimates are $3.33 billion in revenue and $1.08 in earnings per share (EPS).

I'm not too worried about Q3 results -- instead, I'd rather look ahead. Investors already know that Arista is growing quickly. What they need to know now is whether demand for their networking equipment will remain strong as cloud computing companies continue to expand their AI infrastructure.

That's why fourth-quarter guidance could be more important than the third-quarter results themselves.

$182.68+$5.70 (+3.22%)

NYSE · As of 2:33 PM ET 10/19/26

Arista's path to topping Wall Street expectations
Arista has been introducing new networking products designed to handle increasingly demanding AI workloads.

Its 7060XE7 platform supports connections running at 1.6 terabits per second, while its recently announced Etherlink SU-144 architecture can connect up to 144 AI accelerators within a single-hop network.

Those capabilities are becoming more important as AI data centers grow larger and companies look for ways to get more performance from their expensive processors.

The opportunity is substantial, but so is the competition. Nvidia and Cisco Systems are also pursuing the AI networking market, and Arista depends heavily on spending by major cloud computing companies. Still, I think the company's recent growth gives management a reasonable opportunity to surprise Wall Street.

Arista typically provides quarterly revenue and margin guidance rather than an explicit earnings-per-share forecast. So I'll be watching whether its fourth-quarter revenue outlook exceeds $3.6 billion and whether its projected profitability supports earnings above the $1.15 consensus estimate.

A revenue forecast above expectations would suggest that demand for Arista's networking equipment remains stronger than Wall Street anticipated. Healthy margins would make that growth even more valuable to shareholders.

Getting big returns from financial portfolios, whether through stocks, bonds, ETFs, other securities, or a combination of all, is an investor's dream. But for income investors, generating consistent cash flow from each of your liquid investments is your primary focus.

Cash flow can come from bond interest, interest from other types of investments, and, of course, dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield, a metric that measures the dividend as a percent of the current stock price. Many academic studies show that dividends account for significant portions of long-term returns, with dividend contributions exceeding one-third of total returns in many cases.

Headquartered in Redwood City, Equinix (EQIX - Free Report) is a Finance stock that has seen a price change of 28.69% so far this year. Currently paying a dividend of $5.16 per share, the company has a dividend yield of 2.09%. In comparison, the REIT and Equity Trust - Retail industry's yield is 4.45%, while the S&P 500's yield is 1.38%.

Looking at dividend growth, the company's current annualized dividend of $20.64 is up 10% from last year. Over the last 5 years, Equinix has increased its dividend 5 times on a year-over-year basis for an average annual increase of 13.62%. Looking ahead, future dividend growth will be dependent on earnings growth and payout ratio, which is the proportion of a company's annual earnings per share that it pays out as a dividend. Equinix's current payout ratio is 50%, meaning it paid out 50% of its trailing 12-month EPS as dividend.

Looking at this fiscal year, EQIX expects solid earnings growth. The Zacks Consensus Estimate for 2026 is $43.45 per share, representing a year-over-year earnings growth rate of 13.36%.

Investors like dividends for many reasons; they greatly improve stock investing profits, decrease overall portfolio risk, and carry tax advantages, among others. However, not all companies offer a quarterly payout.

High-growth firms or tech start-ups, for example, rarely provide their shareholders a dividend, while larger, more established companies that have more secure profits are often seen as the best dividend options. Income investors must be conscious of the fact that high-yielding stocks tend to struggle during periods of rising interest rates. With that in mind, EQIX is a compelling investment opportunity. Not only is it a strong dividend play, but the stock currently sits at a Zacks Rank of #3 (Hold).

NEW YORK, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP (“Wolf Haldenstein”), a nationally recognized securities litigation law firm, announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS) on behalf of investors that purchased or otherwise acquired Hims & Hers securities between August 4, 22025,and July 29, 2026 (the "Class Period").

Investors who purchased Hims & Hers shares during the class period and suffered losses may be eligible to participate in the case, with the lead-plaintiff deadline set for November 2, 2026.

PLEASE CLICK HERE TO SUBMIT CONTACT AND TRADE INFORMATION

The filed complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failing to disclose material adverse facts to investors, including that

the Company shared consumers' health information with third-party advertising platforms;
the Company charges consumers for prescriptions almost immediately after they submit an intake form, despite telling consumers that they will be able to consult with a medical provider to find a treatment that is "right for them;"
the foregoing conduct subjected the Company to regulatory scrutiny;
because of the foregoing, the Company was reasonably likely to incur fees and penalties; and
because of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. On July 29, 2026, the Federal Trade Commission ("FTC"), the People of the State of California through Los Angeles County Counsel and the Utah Division of Consumer Protection sued Hims & Hers in the Northern District of California. According to the FTC, the action alleges that Hims & Hers fails to clearly disclose that it charges consumers for prescriptions almost immediately after they submit an intake form, despite telling consumers that they will be able to consult with a medical provider to find treatment that is "right for them." The FTC also alleges that the company has made it difficult for consumers to cancel subscriptions and misled consumers about keeping their health information private. The FTC alleges that Hims shared consumers' health information with Meta, Snap and other third parties.

Following this news, the price of Hims & Hers stock fell $4.32 per share, or 14.73%, to close at $25.00 per share on July 29, 2026.

WHY WOLF HALDENSTEIN?

This illustrious firm, founded in 1888, is steadfast in their pursuit of justice for investors who have suffered financial harm due to these misrepresented statements. The law firm brings to the fore over 125 years of legal expertise in securities litigation and has a proven record of protecting the rights of investors.

We encourage all investors who have been affected or have information that will assist in our investigation, to contact Wolf Haldenstein Adler Freeman & Herz LLP.

There is no cost or obligation to speak with an attorney.

Contact:

Phone: (800) 575-0735 or (212) 545-4774Email: [email protected] Person: Gregory Stone, Director of Case and Financial Analysis Firm Website: Wolf Haldenstein Adler Freeman & Herz LLP

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Adds details throughout

Oct 19 (Reuters) - Hong Kong-listed Metis TechBio 7666.HK said on Monday it has entered into a collaboration agreement with Eli Lilly LLY.N worth up to $1.1 billion to research and develop tissue-specific drug delivery technologies.

The Chinese biotech will use its proprietary AI-driven drug-delivery platform to develop next-generation technologies aimed at improving how LNP-based drugs reach target tissues.

Metis will be eligible to receive an upfront payment in the low double-digit millions US dollars and up to about $1.1 billion in development, regulatory and commercial milestone payments.

It will also be eligible for tiered royalties at a single-digit percentage of annual net sales of products that are developed due to the collaboration.

The Chinese biotech will use its proprietary AI-driven ionizable lipid discovery and optimisation platform to develop delivery technologies aimed at improving the targeting and biodistribution of LNP-based therapies.

Metis and Lilly aim to discover and optimise novel LNP architectures that could improve tissue specificity and therapeutic performance, with potential applications across multiple disease areas.

(Reporting by Nikita Maria Jino and Kumar Tanishk in Bengaluru; Editing by Joyjeet Das)

SummaryCoreWeave, Inc. has sold off sharply, but I'm upgrading to a Strong Buy, as de-risking appears overdone and risk-reward is now favorable.Despite credit market stress and sector-wide AI bubble fears, CRWV’s deep Nvidia relationship and large backlog support my investment thesis.Valuation is compelling: CRWV trades at 10.6x forward EBITDA, a steep discount to peers, already pricing in much of the financing risk.If CRWV converts backlog to revenue and secures cheaper, contract-backed funding, financing fears should fade and upside potential remains strong. Richard ODonoghue/iStock via Getty Images

CoreWeave, Inc. (CRWV) led the AI selloff last week. The stock is now down over 27% over the past month, 48% over the past 6 months, and another 14% year to date. This selloff looks almost identical

5.55K Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Shares of Sandisk (SNDK +6.05%) charged sharply higher on Monday, jumping as much as 8.3%. As of 11:24 a.m. ET, the stock was still up 7.9%.

While a rebound in technology issues certainly helped, the semiconductor specialist rallied on positive news in the high-bandwidth memory (HBM) space.

Image source: The Motley Fool.

Industry standardEarlier this year, Nvidia (NVDA +1.78%) announced the development of NVHBM, the company's custom HBM architecture. NVHBM is a custom HBM die that delivers 15% lower power consumption and 30% higher bandwidth, all on a smaller die than HBM4e. To be clear, this isn't a replacement for traditional HBM, but rather connective technology between Nvidia's NVLink and HBM chips.

A report emerged over the weekend that Nvidia has asked Samsung Electronics to adopt Taiwan Semiconductor Manufacturing's 3-nanometer chipmaking process to produce the NVHBM dies, according to a story that first appeared in the Seoul Economic Daily. This will mark the first such collaboration between TSMC and Samsung, according to the report.

SNDK Sandisk$1,377.94+$78.64 (+6.05%)

NASDAQ · As of 1:27 PM ET 10/19/26

Moreover, Nvidia has approached the industry's biggest memory producers, including Micron Technology and SK Hynix, to use this process, which would standardize it across multiple memory suppliers. This, in turn, would free up valuable real estate on the compute die, resulting in up to 30% additional compute.

Investors have been concerned that demand for artificial intelligence (AI) could falter, thereby reducing demand for the AI chips. This move by Nvidia suggests that -- despite fears to the contrary -- the adoption of AI still has room to run. This suggests that the same is true for memory chip suppliers.

Even in the face of unprecedented demand for memory chips, Sandisk stock is selling for just 19 times earnings and 6 times forward earnings. This gives investors the opportunity to pick up shares at a discount.

Danny Vena, CPA has positions in Micron Technology, Nvidia, and Sandisk. The Motley Fool has positions in and recommends Micron Technology, Nvidia, and Taiwan Semiconductor Manufacturing. The Motley Fool has a disclosure policy.

Florida's governor just made a bold promise about Tesla's flying Roadster, and the stock market is already reacting in ways that separate Tesla from every other EV maker on the board.

A pledge from Florida’s governor is lifting one electric vehicle maker while its smaller rivals retreat. Tesla (NASDAQ:TSLA | TSLA Price Prediction) shares are up 4% to $367.59 in afternoon trading after Florida Governor Ron DeSantis promised to make the company’s flying Roadster legal in his state.

Meanwhile, Rivian Automotive (NASDAQ:RIVN) shares are down 0.9% to $12.31, trailing well behind the gain in Tesla shares, and Lucid Group (NASDAQ:LCID) is off by 1.12% to $3.10.

The divergence points to a reaction to the Roadster headline that’s specific to Tesla, and Rivian and Lucid are smaller pure-play EV makers that aren’t yet profitable.

DeSantis Pledges Florida Will Make the Roadster Legal
Florida Governor Ron DeSantis took to X. He declared that his state will make Tesla’s flying Roadster legal, writing, “We will make sure that it’s legal.” His comments followed Tesla’s revealing of the long-delayed Roadster last week.

At that event, a version of the Roadster fitted with air tanks and thrusters launched off a ramp, flew briefly and landed on its wheels. The demonstration turned a sports car Tesla has promised for years into a showcase for its engineering ambitions, and the governor’s pledge now adds a political boost.

Tesla stock is also rising alongside a broad rebound in technology names, so the Roadster headline is one of two forces behind the move. Large-cap tech is strong, with the Invesco QQQ Trust (NASDAQ:QQQ) up 2%. That gap with Tesla stock suggests the Roadster pledge is giving Tesla an extra boost on top of the tech rally.

Tesla Pulls Away From Rivian and Lucid
The Global X Autonomous & Electric Vehicles ETF (NASDAQ:DRIV) is up 1%, a smaller advance than Tesla shares are posting. Its portfolio spans automakers, chipmakers, battery suppliers and autonomy software firms, which reduces the effect of any headline about a single company.

Rivian builds the R1T pickup, the R1S SUV and commercial electric delivery vans, and it’s launching the mid-size R2 SUV to reach a broader market. Lucid designs the Air sedan and the Gravity SUV, assembling them in Arizona while preparing a second plant in Saudi Arabia for production. A software and services section, including a joint venture with Volkswagen Group, gives Rivian another source of revenue.

Closer to the governor’s home state, Tesla runs its Robotaxi service in several U.S. metros, including unsupervised rides in Miami, Orlando and Tampa. That Florida presence gives the governor’s endorsement extra weight for Tesla. Cybercab production has also begun at Tesla’s Gigafactory Texas, and lines for the Optimus humanoid robot are being installed.

Roadster Hype Meets Regulatory Reality
Federal regulators decide whether a vehicle can fly, so Florida’s endorsement carries mostly symbolic weight, and production isn’t expected for years while Tesla hasn’t announced a price for the flying version.

Optimists see the Roadster as evidence Tesla can still generate excitement around new hardware. However, a vehicle years from production and lacking federal clearance may add little to Tesla’s near-term results. Tesla’s growth pitch already leans on Full Self-Driving software, Megapack batteries and the Robotaxi service, leaving the Roadster at its edge.

Washington Holds the Key to the Flying Roadster
The next test for Tesla is whether the flying Roadster ever clears federal approval. Shareholders can watch for whether Florida officials follow up with details on how the state intends to honor the governor’s pledge.

A rally in Tesla shares while Rivian and Lucid shares are slipping shows the Roadster headline lifting a single name in the EV group. Traders may prefer to keep their TSLA stock exposure reasonably small. It’s wise to do so until the flying Roadster’s path to production resolves, the kind of fenced-off speculation we spelled out in a free guide to small-stakes bets.

Contact [email protected] for any questions or corrections.

A Reddit trader claims he rode an AMD position all the way to $16 million, then cashed out completely, convinced the market had finally broken. Now the question is whether he read the signs right or walked away from something…

A trader on Reddit’s r/wallstreetbets says he turned an Advanced Micro Devices (NASDAQ:AMD | AMD Price Prediction) position into a fortune, then sold all of it. On October 16, 2026, user DubiousChemistry posted “+$16,000,000 on AMD and SOXL. Sold it all,” saying he exited AMD shares bought “last June” along with his Direxion Daily Semiconductor Bull 3X Shares (NYSEARCA:SOXL) trade. He offered to verify the gain with video or brokerage statements. No proof has been posted, so the $16 million figure is still unconfirmed. He explained why he sold:

“I think the market has genuinely cracked under the macro pressure. Not going to open any equity longs for a while.”

Testing the Exit Call Against the Data
AMD rose 361.27% from $114.63 in early June 2025 to $528.75 at Friday’s close. It is up 158% year to date. The stock then fell 9.96% in a week. Jim Cramer described how fast the run happened on Mad Money:

“That’s how AMD could go from $188 in March to $658 by last week. Now we’re finding that maybe these moves were too big, too fast.”

The broader market stayed calm. The VIX peaked at 16.87 on October 14 and closed at 16.46 the next day, which is within its normal range. The day before the post, Taiwan Semiconductor Manufacturing guided fourth-quarter revenue up 58% year over year.

AMD’s Revenue and Earnings Kept Growing
AMD’s second-quarter revenue rose 50.1% to $11.54 billion, ahead of the $11.31 billion consensus. Non-GAAP EPS came in at $1.66, above the $1.61 estimate. Data Center revenue grew 107% to $6.72 billion. CEO Lisa Su said on the call:

“We are still in the early stages of a multi-year AI adoption cycle as deployments grow across a broad set of markets and workloads.”

“We now expect revenue to grow substantially above our prior target of greater than 35%, and we expect to significantly exceed our $20 annual EPS target within our strategic timeframe.”

Third-quarter guidance is about $13 billion. Meta Platforms (NASDAQ:META) plans to deploy up to 6 GW of Instinct GPUs, and Anthropic targets up to 2 GW.

How AMD Stacks Up Against NVIDIA and Intel
Competitor NVIDIA (NASDAQ:NVDA) is up only 17.27% this year and slipped 4.84% last week. Intel (NASDAQ:INTC) gained 156% year to date, then fell 10.59% last week. The selling hit this year’s biggest gainers hardest. On fundamentals, AMD reported its fifth consecutive quarter of record server CPU revenue and took x86 server share from Intel.

Reasons a Seller Might Want Cash
AMD trades at about 199 times earnings. Gaming revenue fell 31%, and supply is constrained. Su said:

“The server CPU supply chain is tight right now, and it has been tight for the first half of the year because much of this demand was unforecasted.”

Reddit sentiment on AMD plummeted from bullish to very bearish. Big institutions disagree. In 13F filings for the second quarter, 11 of 22 tracked funds added shares, while 8 cut.

Did He Sell Too Soon? What to Watch Next
The data shows a stock pulling back after a sharp run while the broader market stayed calm. Helios shipments were scheduled to begin in Q3 2026, so AMD’s third-quarter report will test whether demand is holding up. Riding a mania is one skill; knowing when to walk away is another, and we covered both sides in a free bubble survivor’s handbook. The Reddit member closed with this advice:

“Be grateful for whatever the market gives you, whether that be money or a lesson in mental discipline.”

Got $1,000? Before You Buy AMD, Read ThisIf you have cash sitting in your account right now, give this two minutes. After more than two decades of helping investors beat the market, our top analysts at 24/7 Wall St. put together a definitive report on the Top 10 Stocks To Buy Today. And AMD wasn't one of them.

They combed the entire market. It's not 10 ideas, not 10 stocks everyone is talking about, it's what their research points to as the 10 best stocks to buy right now, and it's free. Read more here and see which stocks made the list -->>

Contact [email protected] for any questions or corrections.

Nvidia on Thursday launched new open-weight models designed for always-on agents and edge computing.

The Nemotron 3.5 Super VL is a large, 120-billion-parameter model geared for agents used by the enterprise. While it uses fewer parameters than the Nemotron 3 Ultra model, Nvidia says it can deliver similar accuracy in instruction-following and tool-use tasks.

At the other end of the spectrum, the company also launched two lightweight Bolt models. These are intended to run locally on the new AI PCs (running the Nvidia RTX Spark chip) and workstations running the DGX Spark. Such PCs, aimed at consumers, programmers, and enterprise knowledge workers, are being released right now into the market through partners like Microsoft and Dell.  

“Any organization that wants to run agents on Nvidia infrastructure now has an open, optimized model for their tier without having to choose between capability and deployability,” Nvidia’s vice president of Open Models and Software, Kari Briski, wrote in the blog post announcing these models.  

Nvidia claims that the Super VL completes tasks faster than competing models from Anthropic and OpenAI (Opus 5, GPT 6.1 Sol, Luna, Astra) when post-trained on specific agentic tasks. These tasks include document intelligence, financial accounting, scientific experimentation, medical insurance claims, and security attack resilience. 

While such claims are standard whenever a major tech company announces a new model, Nvidia has backed it up with a list of heavy-hitter companies that it says are using Super VL. These include Skydance, EY, Ramp, Crowdstrike, Perplexity, and Salesforce.  

Of course, these aren’t the first open-weight models that Nvidia has released that compete with the proprietary frontier labs — companies that are both its customers and its investments. The GPU giant has an entire family of Nemotron models that do everything from multimodal artificial intelligence to reasoning, coding, math, and enterprise automation. 

However, those fast-growing proprietary AI labs are now looking to many other chips and AI system makers beyond Nvidia to power their needs, like AWS’s Trainium and Cerebras, as well as building their own home-grown chips.  

So Nvidia is leaning hard into the trend of enterprise companies wanting to run their own open models in their own data centers. “Unlike closed frontier models, organizations can post-train Super VL on their own data, deploy it on their own infrastructure and own what they build,” Briski wrote. 

But with the announcement or the smaller, local PC models, it is also trying to push forward the nascent trend of consumer AI assistants. While it seems a new AI assistant is introduced every day by startups and Big Tech alike, privacy-weary consumers may not want to invite such agents so deeply into their lives giving them access to info about their families, health, finances, and so on.  

So, while Nvidia hopes to create a new market for itself selling PCs powered by its chips by creating machines that run the models and agents locally, PC users “can delegate everyday projects … without sending those workloads to the cloud,” Briski wrote. 

Of the two Bolt models, Nemotron 3.5 Bolt 74B-A9B 24GB is a 74-billion parameter model designed for local agentic tasks. It is intended to balance speed with reasoning to handle multistep reasoning, tool calling, and web browsing. The smallest Bolt E4B is aimed at conversational agents. 

Super VL and Bolt 74B-A9B are available now, with Bolt E4B coming later this month, Nvidia says. 

When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.

Netflix (NFLX -1.43%) reports earnings on Tuesday, and the company's Co-CEO Ted Sarandos didn't give investors reason to be bullish about the numbers. The company is laying off approximately 6% of its workforce, and Sarandos has recently said that the business simply is "not growing as fast as I want."

These are not things that investors want to see heading into the streaming company's earnings release, as they could suggest a weak quarter is on deck. And that's bad news for a stock that's already been nosediving for much of the year.

Image source: Getty Images.

The company is still on track to hit its forecastDespite the struggles Netflix is facing right now, according to a memo that CNBC has seen, management told its employees that it's still "on track to deliver our full year forecast."

When the company last released earnings in July, it reported 13% revenue growth. It also forecasted that for the full year, its revenue will rise by around 13% to 14%, totaling approximately $51 billion. It's a decent growth rate, but one that clearly management isn't thrilled with. It also comes as Netflix has raised prices this year across all of its plans; investors may have been expecting better growth.

Netflix has been investing more in content and sporting events, and thus, there may be more of a need to show a payoff from such investments.

NFLX Netflix$69.53-$1.01 (-1.43%)

NASDAQ · As of 1:12 PM ET 10/19/26

Netflix's stock is cheap, but is it in danger of going lower?It's been an exceptionally bad year for Netflix, as its shares have fallen more than 25% thus far, while the S&P 500 has risen by around 13%. That's not typically what investors would expect to see from a growing business, and it signifies the worry that the market has about Netflix's future growth; a premium may be hard to justify given the uncertainty ahead.

Currently, the stock is trading at a forward price-to-earnings multiple of under 19, which is in line with the average stock on the S&P 500. Arguably, however, the stock deserves a better multiple given its growth prospects, as sports, gaming, and international expansion could still open up more potential for the business in the long run.

Its growth rate remains solidly in double digits, which is an encouraging sign that even with multiple rate hikes over the years, consumers continue to see compelling value in its streaming plans. The business may need some tweaks, but I don't think it's in as dire a situation as its sell-off this year might suggest; at a reduced valuation, now could be a great time to buy the stock, as I don’t think it’s likely to go a whole lot lower.

Key Takeaways Visa integrates Unified Checkout into Barclaycard's Smartpay Fuse gateway to simplify online payments.One integration supports cards, Click to Pay, digital wallets, Pay by Link and invoicing for U.K. merchants.V's partnership could drive wider adoption of value-added services and strengthen UK merchant relationships.
Visa Inc. (V - Free Report) is expanding its merchant payment capabilities in the United Kingdom through an enhanced partnership with Barclaycard Payments. The companies announced the deployment of V’s Unified Checkout solution, which is designed to simplify online payment acceptance and help merchants improve e-commerce conversion. The agreement builds on their six-decade relationship in payments and acceptance.

Under the arrangement, Barclaycard Payments is integrating Unified Checkout into its Smartpay Fuse payment gateway. A single integration will allow merchants to accept card payments, Click to Pay and digital wallets, while also supporting Pay by Link and invoicing. Its modular, API-driven architecture allows businesses to adapt payment capabilities as customer preferences evolve, while the low-code design reduces development requirements and simplifies the addition of new services.

The move strengthens V’s value-added services portfolio by addressing a practical challenge for merchants: offering convenient payment choices without adding unnecessary technical complexity. A smoother checkout can help reduce abandoned transactions, while flexible payment options may improve customer satisfaction. For Barclaycard Payments, the integration also enhances its gateway offering, potentially making it more attractive to businesses seeking simpler payment management.

The agreement supports V’s broader strategy of expanding its role beyond transaction processing into services that deepen merchant and financial institution relationships. Embedding its technology within an established payment gateway expands Visa’s distribution opportunities and could encourage wider adoption of its value-added services among U.K. merchants.

The partnership could strengthen V’s competitive position as payment providers seek to differentiate themselves through integrated technology, security and merchant services rather than payment processing alone. If executed well, it could support additional services revenue opportunities and reinforce Visa’s merchant relationships.

How Are Competitors Faring?Some of V’s competitors in the payments space include Mastercard Incorporated (MA - Free Report) and American Express Company (AXP - Free Report) .

Mastercard is advancing digital checkout through wider adoption of Click to Pay, tokenization and biometric payment passkeys. MA’s push toward eliminating manual card entry across Europe by 2030 could improve transaction security, merchant conversion and payment efficiency.

American Express is strengthening merchant acceptance through payment gateway solutions, Click to Pay and fraud prevention tools. AXP’s network now covers more than 190 million merchant locations globally, supporting wider payment access and deeper relationships with businesses and cardholders.

Pfizer's 5.8% yield looks tempting until you check what the dividend is actually costing the company relative to its cash generation. The math behind that payout is more uncomfortable than the headline numbers suggest.

Pfizer (NYSE:PFE | PFE Price Prediction) declared its quarterly dividend again on Oct. 6, 2026, at $0.43 per share. That’s the same amount it has paid since early 2025. The board held the payout steady after years of annual raises. The last increase took it from $0.42, a bump of about 2.4%. With shares at $29.58, up 24.96% year to date, the stock still yields roughly 5.80%. That raises the question: can Pfizer keep paying it?

Earnings Cover the Dividend, but Cash Flow Is Thin Pfizer’s 2026 adjusted EPS guidance is $2.80 to $3.00. Against that guidance, the $1.72 annual dividend works out to a payout ratio of about 57% to 61%. Cash flow looks less comfortable. In 2025, operating cash flow minus capital spending came to about $9.08 billion, while dividends cost $9.77 billion. That means the payout ate up about 108% of free cash flow. In the first half of 2026, free cash flow was roughly $2.48 billion, while the company paid $4.9 billion to shareholders. GAAP profits keep taking hits from write-downs, including a $3.8 billion impairment on Sigvotatug vedotin in the second quarter.

Debt From Pfizer’s Dealmaking Limits Its Options Total debt rose from $35.8 billion at the end of 2022 to $63.2 billion by June 30, 2026, while cash sat at just $976 million. Management put leverage at 2.7 times and offered no promise that it would fall soon:

“Given the LOE impact over the next few years, we expect leverage to remain around current level or modestly higher through this transition period.”

Buybacks are on hold. Pfizer’s 2026 guidance assumes no share repurchases, and $3.3 billion of authorization remains unused.

Pfizer’s Plan to Replace Revenue Lost to Patent Expirations Generic and biosimilar competition will cost Pfizer about $1.1 billion in revenue this year, and the larger loss-of-exclusivity (LOE) wave, when key patents expire, is still to come. To offset it, launched and acquired products grew 18% operationally in the second quarter. A patent settlement extends U.S. exclusivity for Vyndamax, a heart-disease drug, to June 2031. Cost programs aim for about $9.7 billion in net savings through 2029. Chief executive Albert Bourla addressed the payout directly on the second-quarter call:

“We feel extremely confident that, even in the most stretched scenarios that we are running, we will be able to maintain our dividend. So I want, once and for all, to make that clear to all: the dividend will be maintained, and eventually, after the LOE period, we will start growing it again.”

He also pointed to a “risk-adjusted, high single-digit revenue CAGR from year-end 2028 through year-end 2033,” with obesity drugs from the Metsera deal aiming for a first approval in 2028.

How Bristol Myers and Merck Compare Despite its own generic erosion, Bristol-Myers Squibb (NYSE:BMY) still raised its dividend to $0.63 per quarter. That was a 1.6% increase and its 17th consecutive annual raise. Bristol also lifted its 2026 EPS outlook to $6.75 to $7.00. Chief executive Christopher Boerner said, “The Growth Portfolio continues to deliver.”

Merck (NYSE:MRK) is paying the cost of rebuilding its pipeline. One-time charges of $9.0 billion for Cidara and $5.7 billion for Terns pulled its 2026 non-GAAP EPS outlook down to $2.66 to $2.76. Merck can absorb charges of that size from a $360 billion market cap. Pfizer is worth about $168.6 billion.

Verdict: Safe for Now, With No Growth Until the End of the Decade Adjusted earnings cover the dividend well, and management has staked its credibility on keeping it. Free cash flow, though, has fallen short of the payout, and the debt load leaves little room for error. The current $0.43 looks safe through the patent-expiration years. Pfizer’s own plan also makes clear that raises are unlikely to resume before the 2029 return to growth. Until then, keep an eye on free cash flow coverage and leverage.

Contact [email protected] for any questions or corrections.

Cisco's AI order book has management calling it a networking supercycle, and shareholders want to know if a $200 share price is the payoff. A fresh model breaks down exactly how far the rally can realistically run and what stands…

Cisco Systems (NASDAQ:CSCO | CSCO Price Prediction) has run hard on AI networking demand, and the obvious next question for shareholders is whether $200 a share is on the horizon. We modeled what a $1,000 investment could become by 2031, starting from a reference price of $113.64.

Shares were changing hands near $109.13 noon, down 3.97% on the session. With an AI order book that management calls a supercycle, Cisco deserves a fresh forward look.

Your $1,000 Could Reach About $1,563.50 by 2031 In the five-year base case, a $1,000 investment might reach roughly $1,563.50 by 2031, a total return of 56.35%. The estimate assumes a modeled share price of $177.67 on October 15, 2031, which works out to 9.35% a year.

Neither horizon in the model gets Cisco to $200. The highest target is the five-year bull case at $187.86. Getting to $200 from the reference price would take a gain of 75.9944%. That makes $200 an hypothetical stretch scenario beyond 2031. The model gives no date for it.

Bull, Base and Bear Scenarios for a $1,000 Stake Scenario Horizon Target Price Total Return Value of $1,000 Bull 2031 $187.86 65.31% $1,653.10 Base 2031 $177.67 56.35% $1,563.50 Bear 2031 $120.89 6.38% $1,063.80 Bull 2027 $138.12 21.54% $1,215.40 Base 2027 $130.14 14.52% $1,145.20 Bear 2027 $109.27 -3.84% $961.60 The model gives its forecast a confidence score of 0.9, which it rates as high. Wall Street’s consensus target is $136.16. The analyst count is 5 strong buys, 14 buys, 10 holds and 0 sells.

Three Drivers Behind Cisco’s Upside Case AI Orders Are Turning Into Revenue Cisco took in $9.30B of AI orders in fiscal 2026 and guided AI infrastructure revenue to about $7.5B in fiscal 2027, up from roughly $4 billion. Chief Executive Chuck Robbins called it “a multi-year, multi-billion dollar networking super cycle.” In the fourth quarter, networking product orders grew 40% year over year.

Guidance Points to Faster Earnings Growth Management expects fiscal 2027 revenue of $72.2B to $73.4B and non-GAAP EPS of $5.05 to $5.11, compared with $4.33 in fiscal 2026. The model works from forward EPS of $5.146 and a forward P/E of 22. A higher multiple on those earnings is how the long-term path gets built.

Consistent Beats and Steady Capital Returns Cisco has exceeded EPS estimates for 6 consecutive quarters. Its latest report showed $1.22 against a $1.17 estimate, on revenue of $17.25B. Shareholders collect a $0.42 quarterly dividend, and $8.1B remains on the buyback authorization.

Risks That Could Sink the Projection Margins are already under pressure. Non-GAAP gross margin fell to 66.3% from 68.4% as AI hardware took a larger share of the mix, and the CFO expects a slight drag in fiscal 2027. The AI growth story leans on hyperscaler capital spending, which can change fast (we covered seven of the suppliers riding that expansion, from power to networking, in a free report here).

Fiscal 2027 guidance already includes tariffs and a restructuring plan announced on May 13, 2026, and execution on both could fell. Geopolitics and supply constraints add further uncertainty.

The stock is also volatile. Shares are up 61.84% over the past year but down 7.04% over the past week, and the 52-week high is $129.38.

Retail view is also marked as bearish. The next test comes with the fiscal first-quarter earnings report on November 12, 2026, where guidance calls for revenue of $18.0B to $18.2B.

What Your $1,000 Could Become By 2031, the model puts a $1,000 Cisco investment somewhere between $1,063.80 and $1,653.10, with $1,563.50 as the base case. A $200 share price stands above even the bull case, so it remains outside the modeled outcomes. The modeled scenarios above do not constitute investment advice.

Contact [email protected] for any questions or corrections.

SummaryMicron Technology, Inc. is re-rated as a Buy, supported by strong revenue visibility, pricing power, and robust demand through FY30.CXMT’s technological advancements pose a long-term threat, but meaningful competitive impact on MU is unlikely before 2028.MU’s HBM segment is narrowing its margin gap with conventional DRAM, with higher selling prices and strong demand driving margin expansion in FY27.With a $150B backlog and 35%+ revenue covered through 2030, MU’s risk-reward profile remains attractive despite competitive and supply risks. amgun/iStock via Getty Images

Investment Thesis Investors are punishing AI-related stocks due to many of them needing to take on high debt to expand their operations and build new data centers.

Since my last coverage, Micron Technology, Inc. (

1.81K Followers

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Eli Lilly just crushed earnings again and sits within striking distance of its all-time high, but a looming price war with Novo Nordisk and a dangerously concentrated revenue base raise real questions about how long the momentum holds.

The 24/7 Wall St. price target for Eli Lilly (NYSE:LLY | LLY Price Prediction) is $1,478.22 over the next 12 months. Shares trade near $1,267.90 at noon, so the target means 16.6% upside. Our model rates Lilly a buy with 90% confidence.

24/7 Wall St. Price Target Summary

Metric
Value

Current Price
$1,267.90

24/7 Wall St. Price Target
$1,478.22

Upside
16.6%

Recommendation
BUY

Confidence Level
90%

That confidence reflects earnings momentum few mega-caps can match. Lilly has beaten EPS estimates for five straight quarters, raised full-year guidance, and holds the next major obesity catalyst in retatrutide. The incretin business should carry earnings well into 2027, according to the model.

Lilly Rallies Toward Its 52-Week High After Another Guidance Raise
Lilly gained 4.89% in today’s session after healthcare stocks including Lilly, Merck and AbbVie rallied Wednesday. Shares are up 6.66% over a week, 11.39% over a month, 18.55% year to date and 57.07% over the past year. The stock sits 1.9% below its 52-week high of $1,292.65 and 62.8% above its low of $778.94.

In Q2, revenue rose 47.67% to $22.97 billion, beating the $20.69 billion estimate, while EPS of $8.38 exceeded the $6.58 forecast. Mounjaro sales grew 91% to $9.94 billion. Management raised 2026 revenue guidance to $85 billion to $87 billion.

Why Bulls See $1,700 Ahead
Retatrutide is the main catalyst, with a U.S. filing planned for Q1 2027. On the Q2 call, Lilly’s CEO said, “We have a pretty large lead over any competitors with a triple acting medicine.” The oral GLP-1 Foundayo grew from about 8,000 to 36,000 prescribers, and the Medicare GLP-1 Bridge Program opened coverage to 20 million eligible Americans.

Wall Street agrees: 25 analysts rate the stock a buy or strong buy, with a consensus target of $1,330.14. Jim Cramer said in June he is “sticking with Lilly for the long haul.” Our bull case reaches $1,699.82, or 34.1% upside.

Pricing Pressure Is the Risk to Respect
Realized prices fell 13% in Q2, and Novo Nordisk (NYSE:NVO) plans to cut Wegovy’s list price by about 50% starting January 1, 2027. Mounjaro and Zepbound produced $14.9 billion of Q2 revenue, a heavy concentration, and guidance excludes pharma tariffs.

Volume growth of 60% more than covered the price cuts, though. The $2.78 billion in acquired R&D charges reflect pipeline spending that won’t repeat. The bear case of $1,245.07 sits only 1.8% below today’s price.

Lilly Outgrows Novo Nordisk and Pfizer by a Wide Margin
Novo Nordisk is Lilly’s direct GLP-1 rival. Its Q2 adjusted sales grew just 7% at constant currency, and it still guides to a 2026 decline of 0% to 6%. That gap explains why investors pay up for Lilly.

Pfizer (NYSE:PFE) shows the valuation trade-off. It trades at a P/E of about 21, compared with Lilly’s trailing 40 and forward 24. Pfizer’s revenue grew only 2.6%, however, as COVID sales faded.

Company
Latest Quarterly Revenue Growth
Operating Margin

Eli Lilly
47.67%
54.2%

Novo Nordisk
7% (adjusted, CER)
41.3%

Pfizer
2.6%
24.7%

Lilly’s forward multiple sits only a few turns above Pfizer’s P/E, even though Lilly is growing far faster. Against that background, our 24/7 Wall St. price target looks reasonable.

Lilly’s Growth Justifies the Premium
The 24/7 Wall St. price target of $1,478.22 carries a buy rating at 90% confidence. What tips the scale is volume growth outpacing price cuts.

The bull case strengthens if retatrutide’s filing stays on schedule and Foundayo keeps gaining share. The outlook weakens if realized prices drop faster after Novo’s 2027 list-price cuts. For now, Lilly’s earnings support a higher stock price.

Eli Lilly Price Prediction 2026-2030
The model projects where Lilly could trade if current growth trends and market conditions hold.

Target Date
Base Case
Bull Case

December 2026
$1,243.28
$1,284.43

October 2027
$1,478.89
$1,591.40

October 2028
$1,713.01
$1,937.42

October 2029
$1,894.05
$2,231.53

October 2030
$2,074.95
$2,492.66

Lilly would need to keep executing on its incretin strategy for these projections to hold. Retatrutide’s approval timing and U.S. drug-pricing policy could move results sharply in either direction from these tracks.

Contact [email protected] for any questions or corrections.

The market expects Nucor (NUE - Free Report) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.

The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on October 26. On the other hand, if they miss, the stock may move lower.

While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.

Zacks Consensus EstimateThis steel company is expected to post quarterly earnings of $5.71 per share in its upcoming report, which represents a year-over-year change of +117.1%.

Revenues are expected to be $10.53 billion, up 23.6% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 9.11% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Nucor?For Nucor, the Most Accurate Estimate is the same as the Zacks Consensus Estimate, suggesting that there are no recent analyst views which differ from what have been considered to derive the consensus estimate. This has resulted in an Earnings ESP of 0%.

On the other hand, the stock currently carries a Zacks Rank of #1.

So, this combination makes it difficult to conclusively predict that Nucor will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Nucor would post earnings of $4.57 per share when it actually produced earnings of $4.84, delivering a surprise of +5.91%.

Over the last four quarters, the company has beaten consensus EPS estimates three times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Nucor doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

Image: Bigstock

Read MoreHide Full Article

Key Takeaways WDAY launches Workday Decision Intelligence to unify workforce and financial data for faster decisions.The platform helps HR and finance teams analyze costs, risks, margins and forecasts in real time.Scenario analysis, approval workflows and insights from past decisions help improve planning and efficiency.
Workday, Inc. (WDAY - Free Report) has introduced Decision Intelligence, an artificial intelligence (AI)-powered solution that helps HR and finance teams evaluate workforce and financial decisions through a unified platform. The solution aims to reduce reliance on spreadsheets and disconnected systems by providing secure access to real-time enterprise data, helping businesses make faster, more informed decisions.

Workday Decision Intelligence enables users to ask questions in simple language, analyze business performance, compare options and take action securely. HR teams can use it to plan hiring, identify skills gaps and improve employee retention while assessing costs and risks. Finance teams can track revenue changes, profit margins, expenses and forecast variances to make better decisions.

The platform also enables organizations to evaluate business scenarios and route recommendations through established approval processes. By reviewing previous decisions, teams can identify effective strategies and improve future planning. Unity Technologies has reported benefits from using the solution to investigate revenue variances and streamline financial reporting.

With this expansion, Workday reinforces its focus on AI-powered business solutions. By combining workforce and financial data, the company aims to help businesses compare options, improve efficiency and respond faster to changing business needs.

Workday’s PeersFortinet, Inc. (FTNT - Free Report) is incorporating AI into its enterprise security solutions to help businesses monitor networks and respond to potential threats. Its technology combines AI-driven analysis with automated security tools, helping companies to manage risks and protect their digital infrastructure. Fortinet continues to develop intelligent security solutions as businesses face increasingly complex technology challenges.

Snap Inc. (SNAP - Free Report) is leveraging AI to make its digital platforms more engaging and improve advertising performance. The company uses AI to personalize content, enhance augmented reality features and help advertisers reach relevant audiences. These capabilities support Snap’s efforts to improve user engagement and create new opportunities in digital advertising.

Palo Alto Networks, Inc. (PANW - Free Report) is applying AI to simplify enterprise operations and help businesses make better use of their data. Its AI-powered capabilities support workflow automation, data analysis and more efficient business process management. Palo Alto Networks is expanding these solutions to help enterprises reduce manual work and improve productivity.

Published in artificial-intelligence cloud-computing tech-stocks

Arkham has reported more than 35 million labels on Robinhood Chain, saying its platform supports searches for every address, transfer, and transaction identifier on the Ethereum layer-2 network.

Summary

Arkham says Robinhood Chain has over 35 million labels, with searchable addresses, transfers, and transaction identifiers. Its tools support wallet tracking, entity analysis, and custom alerts for onchain activity. Arkham’s July 22 announcement confirms the integration predates its latest October post. Robinhood’s Stock Tokens remain unavailable to US persons under the company’s product restrictions. Arkham said in an Oct. 19 post that its labels, alerts and tracing tools are live on the chain. Its website dates an earlier integration announcement to July 22, when the company described support for tracking traders, monitoring transfers and accessing network data through its API.

Arkham’s Robinhood Chain support predates the latest post The October announcement puts a figure on Arkham’s labeling coverage while repeating the availability of its blockchain intelligence tools.

“We’re live on Robinhood Chain, bringing Arkham’s labels, alerts and tracing tools to Robinhood Chain,” the company wrote.

In its July announcement, Arkham described full endpoint integration for Robinhood Chain through its application programming interface. The company said calls available for other supported chains could be made for Robinhood Chain, alongside alerts for large fund movements and tools for following token prices.

By September, Arkham’s published research described the network as integrated into its multichain explorer. That article listed transaction searches, holder-concentration monitoring, and custom alerts for transfers, liquidity movements, and activity involving wallets or entities.

Neither the earlier announcement nor the supplied October post provides a matching Ethereum label count or a chain-by-chain coverage methodology. The 35 million figure remains Arkham’s reported total, without an independently established comparison of labeling depth between the two networks.

Robinhood Chain searches cover wallets and counterparties Arkham’s research describes several ways to examine activity beyond searching for a transaction identifier, commonly called a TXID.

According to the company, entering a Robinhood Chain address can display its historical balances, current portfolio, and leading counterparties. Its entity-clustering feature groups addresses attributed to a known entity so users can examine aggregate holdings.

The same research says users can trace transfers in real time and inspect specific payments or smart-contract executions through the platform’s search bar. Arkham presented those functions alongside examples of traders operating in the network’s memecoin markets.

Robinhood’s developer documentation separately lists Blockscout explorers for mainnet and testnet. It identifies Alchemy as its recommended infrastructure provider and directs developers seeking historical reads and indexing to archive endpoints available through infrastructure providers.

For network configuration, the documentation specifies mainnet chain ID 4663 and testnet chain ID 46630. Both use ETH as their currency, while Robinhood Chain uses Ethereum blobs for data availability.

The documentation distinguishes public endpoints from production infrastructure. Public endpoints are rate-limited, and Robinhood recommends a provider for production use. Developers can obtain standard transaction and account data through those services, while Arkham describes its offering through labels, entity groupings, portfolio views and alerts.

Tokenized stocks share the network with memecoin markets Robinhood launched the public mainnet on July 1, describing it as a permissionless layer 2 built using Arbitrum technology. Its launch announcement named Uniswap and Pleiades among the initial trading venues, with infrastructure integrations from Alchemy, BitGo, and Chainlink.

As crypto.news previously reported in its explanation of the network’s tokenized stock structure, Stock Tokens provide exposure to underlying equities while operating as transferable assets within supported onchain applications.

Trading developed around speculative tokens during the network’s first weeks. July 16 coverage of its early memecoin trading activity recorded roughly $312 million in total value locked and 3.6 million daily transactions. CASHCAT, an unaffiliated memecoin associated with Robinhood’s original working name, reached a market capitalization near $156 million.

By Sep. 2, coverage of RWA-linked trading volume cited a $390 million daily total from data compiled by onchain researcher Adam Tehc. Memecoin-stock pairs accounted for $217 million, while tokenized-stock trading contributed $127 million.

Those figures describe historical snapshots, rather than current October trading conditions. The September account described pools pairing memecoins with tokenized versions of companies including Nvidia, Tesla, Intel and Roblox.

Robinhood’s launch statement said eligible Stock Token holders could trade around the clock and use tokens in lending pools or as collateral across decentralized finance applications. Availability varied by jurisdiction, including for products accessed through Robinhood Wallet.

US Stock Token restrictions remain in Robinhood’s disclosures Robinhood’s support page distinguishes the public blockchain from its brokerage and crypto accounts. The company says Robinhood Chain operates independently of the main app and does not affect investments, crypto balances, or portfolios held there.

The same page identifies Robinhood Digital Assets, LLC as the chain’s provider and describes that entity as a software provider that does not offer regulated financial or advisory services.

In its product disclosures, Robinhood identifies Stock Tokens as tokenized debt securities issued by Robinhood Assets (Jersey) Limited. Holders receive economic exposure to underlying securities without legal or beneficial rights in the underlying issuer.

Robinhood says those Stock Tokens are not registered under US securities laws and cannot be offered, sold or delivered in the United States or to US persons. Its disclosures list further restrictions covering jurisdictions including Canada, the United Kingdom and Switzerland.

Sui Network's year-to-date SUI buybacks have reached 915,800 tokens, funded by stablecoin yield and fees. Here is how the program works and what it means for supply.

@SuiNetwork has bought back 915,800 $SUI year-to-date, putting the program within reach of the 1 million token mark. The purchases are funded by protocol-earned stablecoin yield and execution-fee earnings, and are carried out continuously on the open market.

Onchain data shows total protocol earnings of $3.2 million so far in 2026. The earnings are driven by transaction execution density and treasury float income on the Move-based Layer-1 network.

How the Sui buyback mechanism worksThe program converts yield from dollar-based assets held in network reserves into daily spot purchases of $SUI. , according to the network's own buyback dashboard.

The yield largely comes from USDsui, the network's native stablecoin. , CoinDesk reported at launch.

The model links stablecoin growth to token demand. The network's dashboard currently lists .

Buybacks are not burnsUnlike a buyback-and-burn scheme, the program does not shrink supply.

The scale is also modest relative to the market. In an August analysis, AMBCrypto noted that . It concluded the program .

The total has grown steadily since then. by early September, so the latest figure of 915,800 $SUI marks continued accumulation. The pace depends on how much yield the reserves generate, which can vary with stablecoin float and usage.

Sui's reference gas price was also changed this year. , which shifts more of the revenue mix toward stablecoin yield.

SourcesSui Network Revenue & SUI Buybacks (Sui)
Sui's native USDsui stablecoin goes live (CoinDesk)
Sui Buybacks Return Purchased Tokens Without Cutting Total Supply (TokenPost)

While many fuel cell investors are still waiting for their investments to flourish, Bloom Energy (BE +3.51%) shareholders have enjoyed an impressive performance of late. Since the start of 2026, Bloom Energy shares have soared more than 166%.

But it's foolish to assume that simply because Bloom Energy shares have rocketed higher, the stock is a screaming buy. Let's take a closer look at both the good and the bad ahead of the company's reporting of its third-quarter 2026 financial results on Oct. 22.

Image source: Getty Images.

Generating steady free cash flow distinguishes Bloom from fuel cell peers
When evaluating the fundamentals of companies, investors can sometimes struggle to find any semblance of financial well-being. But that's hardly the case with Bloom Energy.

BE Revenue (Annual) data by YCharts.

From growing both revenue and earnings before interest, taxes, depreciation, and amortization (EBITDA) to maintaining a strong balance sheet (Bloom's net debt-to-EBITDA ratio was a conservative 0.35 at the end of Q2 2026), there are numerous indications of the company's impressive financial health. It's what's found on the cash-flow statement, however, that stands out as a bright, green flag.

Generating $175 million in free cash flow for Q2 2026, Bloom Energy has repeatedly produced free cash flow on a trailing-12-month basis for more than a year, proving that its ability to generate organic cash is more than a flash in the pan.

BE Free Cash Flow data by YCharts.

Plus, Bloom Energy's consistent free-cash-flow generation is uncommon among hydrogen-focused companies like Plug Power and FuelCell Energy, which have resorted to raising capital through substantial equity and debt issuances to keep the lights on.

Bloom stock's price tag may have some seeing red
In stellar financial health and with a significant market opportunity (Fortune Business Insights projects the fuel cell industry will grow from $16.8 billion in 2026 to $139 billion in 2034), Bloom Energy is certainly an alluring growth stock. The strong fundamentals, however, come at a cost.

Bloom Energy shares are currently changing hands at 347 times trailing earnings. As if its price-to-earnings (P/E) ratio wasn't steep enough, consider the steep cash-flow multiple: Bloom shares are priced at 109 times operating cash flow.

Because Bloom hasn't consistently generated earnings and positive operating cash flow for several years, it's impossible to compare the stock's current valuation to historical earnings-and cash-flow-based valuations. With respect to sales, though, investors can gain some insight. Trading at a notable premium to its five-year average sales multiple of 3.3, Bloom Energy's stock is changing hands today at 24.3 times trailing sales.

While the stock's valuation will surely deter value investors, those who don't typically prioritize bargain-bin stocks may also find the fuel cell stock's price tag prohibitive.

Should investors power their portfolios with Bloom Energy?
Since its initial public offering (IPO) in 2018, Bloom Energy has ascended into rarified air for hydrogen stocks, demonstrating both robust revenue and earnings growth, though the company's free-cash-flow production that is one of the most alluring qualities right now.

Although Bloom stock is pricey, it's not so pricey that those with multi-year investing horizons should look elsewhere to scratch their itch for quality growth stocks.

Wall Street analysts expect Norfolk Southern (NSC - Free Report) to post quarterly earnings of $3.48 per share in its upcoming report, which indicates a year-over-year increase of 5.5%. Revenues are expected to be $3.46 billion, up 11.6% from the year-ago quarter.

The current level reflects an upward revision of 0.7% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.

Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.

While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.

In light of this perspective, let's dive into the average estimates of certain Norfolk Southern metrics that are commonly tracked and forecasted by Wall Street analysts.

The collective assessment of analysts points to an estimated 'Railway operating revenues- Merchandise- Agriculture, forest and consumer products' of $700.42 million. The estimate points to a change of +11.2% from the year-ago quarter.

The consensus estimate for 'Railway operating revenues- Coal' stands at $417.75 million. The estimate indicates a year-over-year change of +11.4%.

The consensus among analysts is that 'Railway operating revenues- Merchandise- Chemicals' will reach $639.98 million. The estimate indicates a change of +12.5% from the prior-year quarter.

Analysts expect 'Railway operating revenues- Intermodal' to come in at $915.37 million. The estimate indicates a change of +20.6% from the prior-year quarter.

The combined assessment of analysts suggests that 'Railway Operating Ratio' will likely reach 66.1%. Compared to the present estimate, the company reported 64.6% in the same quarter last year.

According to the collective judgment of analysts, 'Revenue ton miles' should come in at 48.48 billion. The estimate compares to the year-ago value of 46.90 billion.

The average prediction of analysts places 'Carloads (Units) - Volume - Merchandise' at 611.45 thousand. Compared to the present estimate, the company reported 595.10 thousand in the same quarter last year.

Analysts predict that the 'Carloads (Units) - Volume - Intermodal' will reach 1.06 million. The estimate compares to the year-ago value of 1.03 million.

Analysts forecast 'Revenue per Carload (Unit) - Total' to reach $1891.03 . The estimate is in contrast to the year-ago figure of $1721.00 .

It is projected by analysts that the 'Revenue per Carload (Unit) - Coal' will reach $2294.84 . Compared to the present estimate, the company reported $2120.00 in the same quarter last year.

Based on the collective assessment of analysts, 'Revenue per Carload (Unit) - Merchandise' should arrive at $3545.47 . Compared to the current estimate, the company reported $3310.00 in the same quarter of the previous year.

Analysts' assessment points toward 'Revenue per Carload (Unit) - Intermodal' reaching $865.30 . Compared to the present estimate, the company reported $735.00 in the same quarter last year.

View all Key Company Metrics for Norfolk Southern here>>>

Shares of Norfolk Southern have experienced a change of +4.1% in the past month compared to the +1.5% move of the Zacks S&P 500 composite. With a Zacks Rank #3 (Hold), NSC is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Key Takeaways FIX's Q3 EPS is expected to jump 53.9%, with revenues projected to rise 36.7% year over year.A record $14.06B backlog and robust data center demand are expected to fuel Mechanical and Electrical growth.FIX's 54.2% year to date rally, 25.2X forward P/E and rising costs raise caution ahead of Q3 earnings.
Comfort Systems USA, Inc. (FIX - Free Report) is slated to report its third-quarter 2026 results on Oct. 22, after market close.

In the last reported quarter, the company’s earnings and revenues topped the Zacks Consensus Estimate by 20.7% and 11%, respectively. Adjusted earnings per share (EPS) of $12.53 surged 91.9% from the year-ago quarter. Revenues of $3.27 billion also rose 50.3% year over year. Operating cash flow reached $1.14 billion, while backlog climbed 73% year over year to a record $14.06 billion. Management remained optimistic about continued growth through 2026 and into 2027, supported by strong project pipelines and expanding modular capabilities.

FIX’s earnings topped the consensus mark in each of the trailing four quarters. The average surprise is shown in the chart below.

Image Source: Zacks Investment Research

How Are Estimates Placed for FIX Stock?The Zacks Consensus Estimate for third-quarter EPS has increased to $12.70 from $12.64 over the past 60 days. The estimate indicates 53.9% growth from the year-ago EPS of $8.25. The consensus mark for revenues is pegged at $3.35 billion, indicating a 36.7% year-over-year increase.

For 2026, Comfort Systems is expected to post a 42.1% increase in revenues from a year ago. Its EPS is expected to grow 67.6% from a year ago. Below is what to expect from FIX stock.

Comfort Systems EPS Estimate

Image Source: Zacks Investment Research

Comfort Systems Revenue Estimate

Image Source: Zacks Investment Research

Factors Likely to Have Defined FIX’s Q3 PerformanceStrong Backlog Likely Supported Revenues: Comfort Systems’ third-quarter 2026 revenues are expected to have benefited from sustained demand for data centers, technology infrastructure and mission-critical facilities. The company entered the quarter with a record backlog of $14.06 billion, providing strong revenue visibility. Continued investments in advanced manufacturing, healthcare, education and government projects are also likely to have supported activity. Management expects full-year 2026 same-store revenue growth in the mid- to high-30% range, indicating continued momentum.

Segment-Wise: Comfort Systems operates through two segments — Mechanical and Electrical.

The Mechanical segment (which accounted for 73.3% of total revenues in 2025) is expected to have benefited from demand for HVAC installations, piping systems and modular fabrication associated with hyperscale data centers and industrial facilities. Expanding modular production capacity and healthy project pipelines are likely to have supported revenues. The Zacks Consensus Estimate for the segment’s revenues is currently pegged at $2.35 billion for the third quarter, up from $1.81 billion reported a year ago.

The Electrical segment (which contributed 26.7% of total revenues in 2025), is expected to have benefited from rising demand for electrical infrastructure, power distribution and control systems across technology and industrial projects. Contributions from the Hunt Electric acquisition, expected to generate approximately $250 million in annualized revenues, should have further supported segmental growth. The Zacks Consensus Estimate for the segment’s revenues is currently pegged at $1.0 billion for the third quarter, up from $640.5 million reported a year ago.

Margins Likely Remained Strong: Third-quarter margins are expected to have benefited from favorable project execution, disciplined bidding, strong pricing and operating leverage. Management anticipates gross margins remaining within the healthy ranges achieved in recent quarters. However, higher workforce expenses and continued investments in modular manufacturing capacity could have partially offset margin gains.

Overall Earnings Expectations: Higher revenues, favorable project mix and operating efficiencies are likely to have supported earnings growth. Management did not provide specific third-quarter guidance but expressed confidence in sustained growth through 2026 and projected a full-year effective tax rate of approximately 23%.

What the Zacks Model Says for FIX StockOur proven model does not conclusively predict an earnings beat for Comfort Systems this time around. A combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. This is not the case here.

FIX’s Earnings ESP: The company has an Earnings ESP of 0.00%. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.

FIX’s Zacks Rank: The company currently carries a Zacks Rank of 4 (Sell).

You can see the complete list of today’s Zacks #1 Rank stocks here.

FIX Stock’s Price PerformanceFIX stock has risen 54.2% year to date, outperforming the Zacks Building Products - Air Conditioner and Heating industry, the Zacks Construction sector and the S&P 500 Index.

FIX Stock’s Price Performance (Year to date)

Image Source: Zacks Investment Research

Comfort Systems operates at a critical level of the artificial intelligence (AI)-driven data center and technology infrastructure boom, competing with Quanta Services, Inc. (PWR - Free Report) , Carrier Global Corporation (CARR - Free Report) and EMCOR Group, Inc. (EME - Free Report) across distinct but overlapping markets. Year to date, FIX has outperformed these major industry peers, with Quanta, EMCOR and Carrier Global gaining 49.7%, 18% and 4.1%, respectively. This outperformance reflects investors’ confidence in Comfort Systems’ strong exposure to high-growth markets, particularly AI data centers, advanced manufacturing and mission-critical infrastructure.

FIX's Price Performance vs Peers (YTD)

Image Source: Zacks Investment Research

FIX’s Valuation TrendFIX stock is currently trading at a premium compared with the industry peers, with a forward 12-month price-to-earnings (P/E) ratio of 25.2, as evidenced by the chart below.

FIX’s Valuation vs Industry (P/E F12M)

Image Source: Zacks Investment Research

At 25.2X forward 12-month earnings, Comfort Systems trades above Carrier Global's 17.22X and EMCOR's 19.84X, suggesting that investors are willing to pay a higher multiple for its growth prospects, strong backlog and exposure to technology-related infrastructure spending. However, FIX remains relatively cheaper than Quanta, which commands a higher multiple of 33.5X. This valuation gap suggests that Comfort Systems offers comparatively more attractive pricing than Quanta, although its premium over Carrier Global and EMCOR leaves limited room for execution setbacks.

Should Investors Sell FIX Stock Before Q3 Earnings?Despite strong backlog growth and healthy demand from data centers and technology infrastructure, investors may consider selling FIX stock ahead of its third-quarter earnings release. The stock’s 54.2% year-to-date rally and premium valuation relative to Carrier Global and EMCOR suggest that much of its growth potential is already priced in. Rising labor costs, capacity expansion expenses and high investor expectations could increase downside risks if results disappoint. FIX’s Zacks Rank #4 reinforces near-term caution. Given these factors, booking profits ahead of the earnings announcement appears prudent.

Wall Street analysts forecast that AppFolio (APPF - Free Report) will report quarterly earnings of $1.78 per share in its upcoming release, pointing to a year-over-year increase of 35.9%. It is anticipated that revenues will amount to $293.84 million, exhibiting an increase of 17.8% compared to the year-ago quarter.

Over the last 30 days, there has been no revision in the consensus EPS estimate for the quarter. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.

Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.

While investors usually depend on consensus earnings and revenue estimates to assess the business performance for the quarter, delving into analysts' forecasts for certain key metrics often provides a more comprehensive understanding.

With that in mind, let's delve into the average projections of some AppFolio metrics that are commonly tracked and projected by analysts on Wall Street.

Analysts' assessment points toward 'Revenue- Other' reaching $1.93 million. The estimate points to a change of -45% from the year-ago quarter.

The average prediction of analysts places 'Revenue- Value Added Services' at $230.99 million. The estimate suggests a change of +20.3% year over year.

The consensus estimate for 'Revenue- Subscription Services' stands at $62.40 million. The estimate indicates a year-over-year change of +16.1%.

View all Key Company Metrics for AppFolio here>>>

AppFolio shares have witnessed a change of -1.2% in the past month, in contrast to the Zacks S&P 500 composite's +1.5% move. With a Zacks Rank #2 (Buy), APPF is expected outperform the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .